Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations

Tomohiro Kato (Himeji, Japan), Tomohiro Kato, Yasuharu Nakahara, Katsuya Hirano, Ryota Kominami, Yasutaka Onishika, Yasushi Fukuda, Ryogo Kagami, Runko Katsuda, Kenji Hanaoka, Yoko Yokoi, Kouhei Miyake, Yasuyuki Mizumori, Hiroaki Tsukamoto, Shin Sasaki, Tetsuji Kawamura, Yoshiro Mochizuki

Source: International Congress 2016 – Prognostic variables in lung cancer I
Session: Prognostic variables in lung cancer I
Session type: Thematic Poster
Number: 2861
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Tomohiro Kato (Himeji, Japan), Tomohiro Kato, Yasuharu Nakahara, Katsuya Hirano, Ryota Kominami, Yasutaka Onishika, Yasushi Fukuda, Ryogo Kagami, Runko Katsuda, Kenji Hanaoka, Yoko Yokoi, Kouhei Miyake, Yasuyuki Mizumori, Hiroaki Tsukamoto, Shin Sasaki, Tetsuji Kawamura, Yoshiro Mochizuki. Prognostic implications of smoking in patients with advanced lung adenocarcinoma excluding positive mutations. Eur Respir J 2016; 48: Suppl. 60, 2861

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prognostic value of smoking status in operated non-small cell lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 40s
Year: 2004

Prognostic parameters in patients with lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 84s
Year: 2006

Prognostic value study of lung cancer molecular markers and value of mitochondrial activity in resected non-small cell lung cancer
Source: Annual Congress 2013 –Prognostic factors and subtyping of lung cancer
Year: 2013

MUC1 associates with smoking, prognosis and histological subtypes in lung adenocarcinoma
Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer
Year: 2015

Molecular signatures of non-small cell lung cancer (NSCLC) obtained from gene expression profiling of the benign bronchial mucosa of smokers with and without NSCLC
Source: Annual Congress 2013 –Biology and molecular pathology of lung cancer
Year: 2013

Differences in epidemiological and clinical features in non-small cell lung cancer (NSCLC) in never and ever smokers
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Prognostic factors affecting survival in advanced non-small cell lung cancer patients
Source: Eur Respir J 2004; 24: Suppl. 48, 75s
Year: 2004

Prognostic value of comorbidity in operated non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 763s
Year: 2006

Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

Prognostic affect of the chronic obstructive pulmonary disease on the local-advanced stage non-small cell lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

The effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016

Clinical features and prognosis of multiple primary malignancies in patients with lung cancer
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013


Prognostic factors for stage IV lung adenocarcinoma patients receiving retreatment with EGFR-TKI
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Clonality of multifocal nonsmall cell lung cancer: implications for staging and therapy
Source: Eur Respir J 2012; 39: 1437-1442
Year: 2012



Locally advanced and metastatic lung cancer management delay: Tunisian department experience
Source: International Congress 2016 – Quality management and quality of life in lung cancer
Year: 2016


Prognostic relevance of histological subtypes in lung cancer – Survival in frequent and rare entities
Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases
Year: 2013

Prevalence of mutations in Romanian patients with non-squamous lung carcinoma evaluated through next generation sequencing
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Prognostic relevance of the new lung cancer classification in operable stages
Source: International Congress 2014 – The more in-depth classification of lung cancer: relevance for patients and science
Year: 2014



Development and validation of a prognostic index for survival in patients with non-small-cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer II
Year: 2016


Prognostic parameters in non-small cell lung cancer (211 cases)
Source: Eur Respir J 2002; 20: Suppl. 38, 268s
Year: 2002